Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · NH

NH

HealthcareHealthcare Services₹38397 cr market cap
₹1873.10 ▼ -0.96% today As of 19 Nov 2026
52-week low ₹1605.3052-week high ₹2080.30

-9.1% from the 52-week high · +17.8% above the low

Narayana Hrudayalaya Ltd. engages in the provision of medical and health care services. The company is headquartered in Bangalore, Karnataka and currently employs 11,726 full-time employees. The company went IPO on 2016-01-06. The firm operates a network of hospitals, diagnostic centers, clinical centers or test laboratories. The firm operates through Medical and Healthcare Services business segment. The firm offers medical, surgery, and diagnostics and support services. The company provides services in the areas of cardiology; orthopedics; cosmetic surgery; anesthesia; imaging and radiology; nutrition and dietetics; physiotherapy; renal transplant; thoracic surgery; pediatrics surgery; medical oncology; surgical gastroenterology; dermatology; hematology; rheumatology; neurology; psychiatry and psychology, and others. The firm operates a network of approximately 20 hospitals (multispecialty and super specialty healthcare facilities), four heart centers and 19 primary care facilities (including clinics and information centers), across India and a hospital at Cayman Islands with approximately 6,181 operational beds.

The short version. NH reported revenue of ₹2,844 crore for Sep 2026, up 73.0% from a year earlier. Net profit was ₹301 crore (up 16.7% year on year). Return on equity was 17.8% in Mar 2026. Promoter holding was 63.27% in Sep 2026, down 0.58 points over 8 quarters.

1 · The price

How has the stock traded?

NH trades 9.1% below its 52-week high and 17.8% above its 52-week low.

Change over period: —

1M+8.6%
3M+5.9%
6M-0.6%
1Y-3.1%

2 · The business

Is it growing?

Sales, year on year+73.0%

Sep 2026 revenue of ₹2,844 cr.

Profit, year on year+16.7%

Sep 2026 net profit of ₹301 cr.

Net margin10.6%

5.1 pts lower than a year earlier.

3-year growth9.9% profit

Revenue compounded at 20.3% over the same 3 years.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue28442684259421511644150714751367
Net profit301207224127258197197193
Net margin %10.67.78.65.915.713.013.414.1
EPS (₹)14.7310.1410.966.212.649.629.659.44

Annual

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue78965483501845253701258231282861
Net profit806790789606342-1411959
Net margin %10.214.415.713.49.2-0.63.82.1
EPS (₹)39.4238.6638.6229.6716.73-0.75.822.9

3 · The quality

How well does it turn capital into profit?

Return on equity was 17.8% in Mar 2026; debt to equity is 1.07.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %17.821.827.428.4
Return on capital %11.417.721.825.9
EBITDA margin %20.824.424.122.5
Net margin %10.114.215.513.2

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR20.3%25.1%
Profit CAGR9.9%—
Debt to equity1.07
Interest cover5.0x
Current ratio2.15
P/E ratio44.7

4 · The owners

Who holds it, and are they adding?

Promoter holding63.27%

Down 0.58 pts over 8 quarters.

Foreign institutions9.01%

Down 0.43 pts over 8 quarters.

Domestic institutions10.68%

Up 1.99 pts over 8 quarters.

Mutual fund schemes118

+26 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter63.8563.8563.8563.8563.2763.2763.2763.27-0.58
FII9.449.6610.4610.4911.19.989.49.01-0.43
DII8.698.528.097.767.919.159.0610.68+1.99
Public17.417.3516.9817.2917.116.9817.6516.42-0.98

Mutual fund holdings · Oct 2026

118 schemes hold this stock

92 the month before.

  • Groww BSE Hospitals ETF5.51% of NAV
  • Bandhan Healthcare Fund3.18% of NAV
  • Taurus Elss Tax Saver Fund3.04% of NAV
  • Mirae Asset Midcap Fund2.12% of NAV
  • the Quantum ESG Best In Class Strategy Fund1.92% of NAV
  • WhiteOak Capital Pharma and Healthcare Fund1.87% of NAV
  • Groww Value Fund1.87% of NAV
  • ADITYA BIRLA SUN LIFE BUSINESS CYCLE FUND1.8% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for NH are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about NH

What is the NH share price?

NH (NH) last closed at ₹1,873.10, down 0.96% on the day. Its 52-week range is ₹1,605.30 to ₹2,080.30.

What is the market cap of NH?

NH has a market capitalisation of about ₹38,397 crore. Its price-to-earnings ratio is 44.7.

How are NH's latest results?

NH reported revenue of ₹2,844 crore for Sep 2026, up 73.0% from a year earlier. Net profit was ₹301 crore (up 16.7% year on year). Return on equity was 17.8% in Mar 2026. Promoter holding was 63.27% in Sep 2026, down 0.58 points over 8 quarters.

Who owns NH?

As of Sep 2026, shareholding was: Promoter 63.27%, FII 9.01%, DII 10.68%, Public 16.42%.

How many mutual funds hold NH?

118 mutual fund schemes held NH in October 2026. That compares with 92 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 01 Aug 2025 · Final Dividend - Rs. 4.5
  • 02 Aug 2024 · Dividend - Rs. 4
  • 07 Jul 2023 · Final Dividend - Rs. 2.5
  • 22 Aug 2022 · Final Dividend - Rs. 1
  • 11 Mar 2020 · Interim Dividend - Rs. 1
  • 01 Aug 2019 · Dividend - Rs. 1

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.